Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Buy
9,847
+54
+0.6% +$13.1K 0.01% 816
2025
Q4
$2.09M Buy
9,793
+1,407
+17% +$289K 0.01% 833
2025
Q3
$1.67M Buy
8,386
+330
+4% +$65.1K 0.01% 838
2025
Q2
$1.69M Buy
8,056
+1,597
+25% +$307K 0.01% 742
2025
Q1
$1.18M Sell
6,459
-108
-2% -$20.7K 0.01% 757
2024
Q4
$1.25M Buy
6,567
+1,367
+26% +$265K 0.02% 674
2024
Q3
$946K Buy
5,200
+3,461
+199% +$568K 0.02% 588
2024
Q2
$275K Buy
+1,739
New +$278K 0.01% 739

Other funds holding WAB

&Partners's WAB Position: Q1 2026 in Review

&Partners increased its Wabtec (WAB) stake by 0.55% in Q1 2026, buying an estimated $13.1K and bringing the position to 9,847 shares worth $2.45M. The position accounts for 0.01% of the portfolio, ranked #816.

&Partners first reported a position in WAB in Q2 2024 and has held it in 8 quarters since. 1,156 funds tracked by Wall St. Rank hold WAB as of Q1 2026.

  • &Partners held 9,847 shares of Wabtec worth $2.45M as of Q1 2026.
  • &Partners bought 54 Wabtec shares in Q1 2026, an estimated $13.1K.
  • Wabtec made up 0.01% of &Partners's portfolio in Q1 2026, its #816 holding.
  • &Partners first reported a position in Wabtec in Q2 2024 and has held it in 8 quarters since.
  • 1,156 funds tracked by Wall St. Rank held Wabtec as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.